Drug induced erythema multiforme of the oral cavity

Nalini Aswath, Rajalakshmi Rakshana


Drug induced erythema multiforme (EM) is a rare clinical entity which majorly involves the oral cavity. It commonly occurs due to intake of drugs such as NSAID’S, certain antibiotics, and anticonvulsants. It is characterized by rapidly rupturing vesicles leading to ill-defined erosions in the oral cavity and encrusted lip lesions. These lesions are usually difficult to differentiate from other vesiculo bullous and ulcerative lesions which would have a similar presentation and the absence of skin lesions can sometimes lead to misdiagnosis. Drug induced EM has an acute onset and is a self-limiting inflammatory hypersensitivity reaction that causes blistering and ulcerations of the skin and mucous membrane. The lesions heal following the discontinuation of the causative medications. This case report describes a case of drug induced Erythema multiforme of the oral cavity that occurred consequent to the intake of Tab.Diclofenac Sodium and Tab.Cephelexin. The patient developed painful, bleeding, burning ulcerations with severe crustations on the upper, and lower lip, lateral and ventral surface of tongue, hard palate and retro molar regions. The case was managed with corticosteroids.


Erythema Multiforme; drug-induced; oral ulcerations; acute self-limiting inflammation

Full Text:



Kohli PS, Kaur J. Erythema multiforme-oral variant: case report and review of literature. Indian J Otolaryngol Head Neck Surg. 2011; 63(Suppl 1):9-12. doi: 10.1007/s12070-011-0169-yPMID: 22754823; PMCID: PMC3146678.

Siegel MA, Balciunas BA. Oral presentation and management of vesiculobullous disorders. Semin Dermatol. 1994; 13(2):78-86. PMID: 8060830.

Grosber M, Alexandre M, Poszepczynska-Guigné E, Revuz J, Roujeau JC. Recurrent erythema multiforme in association with recurrent Mycoplasma pneumoniae infections. J Am Acad Dermatol. 2007 May;56(5 Suppl):S118-9. doi: 10.1016/j.jaad.2006.05.047. PMID: 17434037.

Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin North Am. 2013; 57(4):583-96. doi: 10.1016/j.cden.2013.07.001. PMID: 24034067.

Hasan S, Jangra J, Choudhary P, Mishra S. Erythema Multiforme: A Recent Update. Biomed Pharmacol J 2018;11(1).

Auquier-Dunant A, Mockenhaupt M, Naldi L, et al. Severe Cutaneous Adverse Reactions. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002; 138(8):1019-24. doi: 10.1001/archderm.138.8.1019. PMID: 12164739.

Farthing P, Bagan JV, Scully C. Mucosal disease series. Number IV. Erythema multiforme. Oral Dis. 2005; 11(5):261-7. doi: 10.1111/j.1601-0825.2005.01141.x. PMID: 16120111.

Patel TK, Barvaliya MJ, Sharma D, Tripathi C. A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population. Indian J Dermatol Venereol Leprol. 2013; 79(3):389-98. doi: 10.4103/0378-6323.110749. PMID: 23619444.

DOI: http://dx.doi.org/10.22551/2022.37.0904.10224

Copyright (c) 2022 Nalini Aswath, Rajalakshmi Rakshana

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975